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MIP26Fibroblast growth factor-2 (FGF2)-mediated signaling plays an important role in ﬁber cell differentiation in
eye lens. We had previously shown that kynurenine (KYN) produced from the overexpression of
indoleamine 2,3-dioxygenase (IDO) causes defects in the differentiation of ﬁber cells, induces ﬁber cell
apoptosis and cataract formation in the mouse lens, and leads to cell cycle arrest in cultured mouse lens
epithelial cells (mLEC). In this study, we demonstrate that exogenous KYN reduces FGF2-mediated
expression of α-, β-, and γ-crystallin and MIP26 in mLEC. We show that endogenously produced KYN in
mLEC of IDO transgenic animals causes similar defects in FGF2-induced protein expression and that a
competitive inhibitor of IDO prevents such defects. Our data also show that KYN inhibits FGF2-induced Akt
and ERK1/2 phosphorylation in mLEC, which are required for crystallin and MIP26 expression in the lens.
KYN does not inhibit FGF2 binding to cells but inhibit phosphorylation of FGFR1in mLEC. Together our data
suggest that KYN might inhibit FGF2-mediated ﬁber cell differentiation by preventing expression of
crystallins and MIP26. Our studies provide a novel mechanism by which KYN can exert deleterious effects in
cells.FK, N-formyl kynurenine; KYN,
ous transgenic; MT, 1-methyl-D,
d type; FGF2, ﬁbroblast growth
extracellular-regulated kinase;
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Kynurenines are present in the human lens and are perceived to be
UV light ﬁlters that protect the retina from photodamage [1]. They are
produced from L-tryptophan in the kynurenine pathway. This
pathway is initiated by indoleamine 2,3-dioxygenase (IDO), catalyz-
ing the oxidation of L-tryptophan to N-formyl kynurenine (NFK). This
is eventually converted into nicotinamide adenine dinucleotide
(NAD), through intermediates such as kynurenine (KYN) and 3-OH
kynurenine (3OHKYN) [2].
Kynurenines are unstable under physiological conditions; they
undergo spontaneous deamination to form reactive α,β-unsaturated
ketones [3] that react with nucleophilic amino acids in proteins and
glutathione [4]. Several products of kynurenines have been detected
in the human lens [4–8]. Using highly speciﬁc monoclonal antibodies,
our laboratory provided further evidence for kynurenines modiﬁca-tions in aging and cataractous human lenses [9,10]. In addition to
direct modiﬁcation of proteins, kynurenines indirectly modify
proteins through production of reactive oxygen species [11].
Together, these observations suggest that kynurenines could play an
important role in lens aging and cataract formation.
To further test the role of KYN in lens protein modiﬁcation, in a
recent study, we developed a transgenic (Tg) mouse line that
overexpressed human IDO (hIDO) in the lens [12]. Lenses of
homozygous Tg animals had undifferentiated ﬁber cells and KYN-
modiﬁed proteins and furthermore exhibited dense nuclear cataract.
In a subsequent study, we showed that lens epithelial cells (LEC) from
hemizygous Tg mice showed KYN-mediated G2/M cell cycle arrest
[13].
FGF2 plays an important role in LEC proliferation and differenti-
ation [14,15]. At low concentrations, FGF2 induces LEC proliferation,
while at higher concentrations, it induces differentiation into ﬁber
cells [16]. Studies on transgenic mice have shown that overexpression
of FGF in the lens leads to disruption of normal development of the
lens [17,18]. FGF has several receptors (FGFR1, R2, and R3). Over-
expression of either a truncated, signaling-defective FGF receptor
(FGFR1) [19–21] or secreted FGFR3 [22] results in impaired lens ﬁber
cell differentiation. Furthermore, conditional deletion of FGFR
adversely affects lens morphogenesis [23].
FGF2 signaling is required for crystallin expression during LEC
differentiation [24]. This signaling appears to bemediated by PI3 kinase,
as a selective inhibitor of PI3 kinase blocks FGF2-mediated expression of
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mediated signaling is alsonecessary for the expression ofmajor intrinsic
protein (MIP26), also known as aquaporin 0, the major membrane
protein in the lens [26]. Thus, it is clear that FGF signaling plays an
important role in LEC differentiation.
Our previous ﬁnding that overexpression of IDO led to cell cycle
arrest in LEC andmoreover that KYN caused protein damage and poor
differentiation of LEC, suggests that KYN might affect ﬁber cell
differentiation. The present study was designed to investigate the
effect of KYN on FGF2-induced crystallin andMIP26 expression in LEC.
We provide evidence that both exogenous and endogenous KYN block
FGF2-induced crystallin and MIP26 expression in LEC and that the
blockade occurs via reduction in Akt and ERK1/2 phosphorylation.
2. Materials and methods
2.1. Materials
Recombinant murine ﬁbroblast growth factor (FGF2) was obtained
from PeproTech, NJ. Rabbit polyclonal antibodies speciﬁc to αA- and
αB-crystallinwere fromStressgen,MI, Antibodies toβ- andγ- crystallin,
FGF2, MIP26, FGFR1, and NF-κB (p65) were from Santa Cruz
Biotechnology, CA. Antibodies to total ERK 1/2 and phospho-ERK1/2
(pERK1/2, Thr 202/Tyr 204), Akt, phospho-Akt (pAkt, Ser 473), and
phospho-FGFR1 (pFGFR1, Tyr 653/654) were from Cell Signaling
Technology, MA. Mouse monoclonal antibody to GAPDH was from
Millipore, MA. Eagle's minimum essential medium (MEM) was from
Sigma Aldrich, MO.
2.2. Cell culture and treatment
Our studies conformed to the ARVO Statement on the Use of
Animals in Ophthalmic and Vision Research, and they were approved
by the Case Western Reserve University Institutional Animal Care and
Use Committee.
Mouse lens epithelial cells (mLEC) were isolated from the lens
capsule–epithelial explants of 2- to 3-month-old Wt and IDO hemTg
mice by the method previously described [13]. Cells at passages 4 to 6
were transferred toMEM that had low fetal calf serum (1%) (LSM) and
had 2 mM L-glutamine, 50 μg/mL gentamycin. LSM was essential to
reduce the direct reaction of KYN with serum protein, to facilitate its
effects on mLEC, and to reduce the effects of mitogens present in fetal
calf serum. In addition, a recent study showed that LEC in LSM
resemble early differentiating ﬁber cells [27].
Cells at 50%–60% conﬂuence were treated with FGF2 for 5 days in
LSM (without replacing the medium). In some cases, Wt LEC were
treated with FGF2 and 50 µM KYN. In other cases, hemTg LEC were
treatedwith FGF2 and 20 µM 1-methyl-D,L-tryptophan (MT). KYNwas
dissolved in 25 µl DMSO and further diluted in 10 ml LSM to obtain
the ﬁnal concentration.
2.3. Cell fractionation
To determine nuclear translocation of NF-κB (p65), subcellular
fractionation was performed using the Qproteome Cell Compartment
kit (Qiagen, CA) according to the manufacturer's instructions.
2.4. Western blotting
Trypsinized cells were rinsed thoroughly in ice cold PBS and
proteins were extracted in a lysate solution (10 mM EDTA–0.02%
Triton X-100, pH 10) with phosphatase inhibitor cocktail. Cell lysates
corresponding to 75 µg protein were resolved on SDS–PAGE and
electrophoretically transferred onto a nitrocellulose membrane
(NCM). To determine nuclear translocation of NF-κB (p65), nuclearprotein fractions corresponding to 75 µg protein were resolved on
SDS–PAGE and blotted to NCM.
For detection of crystallins, MIP26, total ERK1/2 and pERK1/2, NF-κB
(p65), pFGFR1 and GAPDH, NCM was blocked with 5% nonfat dry milk
(NFDM) in PBS with 0.2% Tween 20 (PBST) for 2 h at room temperature
(RT), washed with PBST, and subsequently incubated with antibodies
speciﬁc to either αA-crystallin or αB-crystallin, β-crystallin (all 1:1000
diluted); γ-crystallin (1:10,000 diluted); GAPDH (1:10,000 diluted),
MIP26, total ERK1/2,pERK1/2,NF-κB(p65); andpFGFR1(1:1,000diluted)
for 1 h at RT. All primary antibodies were diluted in 5% NFDM/PBST. The
membrane was subsequently washed with PBST, three times 5min each
and incubated with appropriate HRP conjugated secondary antibodies
diluted in PBST for 1 h at RT. After washing, blots were developed with
SuperSignal West Pico Chemiluminescence Kit (Pierce, IL).
For the detection of total Akt and pAkt, NCM was blocked with 5%
NFDM in Tris-buffered saline with 0.2% Tween 20 (TBST) for 1 h at RT,
washed with TBST, and subsequently incubated overnight with
antibodies speciﬁc to total Akt and pAkt (1:1000 diluted) at 4 °C.
Primary antibodies were diluted in TBST with 5% BSA. The membrane
was subsequently washed three times with TBST and incubated with
goat anti-rabbit HRP conjugated IgG (1:2000 diluted in TBST with 5%
NFDM). Membrane was washed with TBST three times, 5 min each,
and developed as described above.
Blot for crystallin and MIP26 expression was stripped and
reprobed for GAPDH (loading control). In the case of pERK1/2 and
pAkt, blots were reprobed for total ERK1/2 and total Akt, respectively.
2.5. ELISA for crystallin expression
ELISA was performed as described previously [13] with modiﬁca-
tions. Brieﬂy, microplate wells were coated with cell lysates in 0.05 M
carbonate buffer (pH 9.6) at a protein concentration of 1 µg/well and
then blocked with 5% NFDM/PBST. The wells were incubated with
antibodies to one of the following:αA-,αB, β-, and γ-crystallins (1:50
diluted in PBS) followed by incubation with HRP-conjugated goat
anti-rabbit IgG (1:10,000 diluted in PBS). The enzyme activity was
assessed by adding 3,3′,5,5′-tetramethylbenzidine and was read at
450 nm. Results were expressed as measures of relative absorbance.
For negative controls, in some cases, wells were incubated with only
the secondary antibody, and in others, wells were coated with BSA
instead of cell lysate.
2.6. Immunocytochemistry
Cells were cultured in 24-well plates, and staining was performed
as previously described [13] with slight modiﬁcations. Brieﬂy, cells
were ﬁxed with 4% paraformaldehyde and permeabilized with 80%
methanol. After blocking with 3% NFDM/1% BSA, wells were
incubated with antibodies to one of the following: FGF2, total ERK1/
2, pERK1/2, NF-κB (p65), and MIP26 (all 1:100 dilution) for 1 h at RT.
The appropriate anti-IgG conjugated to Oregon Green (1:400 diluted)
was used as the secondary antibody. For NF-κB (p65) immunostain-
ing, donkey anti-goat antibody conjugated to Texas Red (1:400
diluted) was used as the secondary antibody.
For pAkt staining, after ﬁxation and permeabilization steps, wells
were blocked with 5% goat serum in PBS/Triton X-100 for 1 h, at RT
and subsequently incubated overnight at 4 °C with anti-pAkt (1:50
diluted in PBS/Triton X-100). After washing with PBS three times for
5 min each, wells were incubated with Oregon Green goat anti-rabbit
IgG (1:400 diluted in PBS/Triton) for 2 h at RT.
In all cases, after secondary antibody incubation wells were washed
with PBST for three times 5 min and permanently mountedwith DAPI/
Vectashield. Cells were viewed with an Olympus System (Model BX60)
ﬂuorescence microscope, and images were acquired with an attached
digital camera (Diagnostic Instruments, Inc., Spot RT Slider) connected
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negative control, cells were stained with only secondary antibodies.2.7. Binding of FGF2 to cells
Cells in MEMmedium (200 cells per well) were plated in a 96-well
plate. After overnight incubation, wells were replaced with LSM (with
or without FGF2, kynurenine, or MT) and incubated for 12 h.
Subsequently, wells were washed with PBS three times (5 min
each), and cells were ﬁxed as described above. After blocking with
3% NFDM/1% BSA in PBS, wells were incubated with anti-FGF2
(1:1000 diluted in blocking solution) for 1 h at RT. After washing with
PBS three times (5 min each), wells were incubated with HRP-
conjugated goat anti-rabbit IgG (1:10,000 diluted in blocking
solution) for 1 h. Wells were washed three times as before, incubated
with the substrate for 20 min, and then treated with 20 μl of 2 N
H2SO4 and read at 450 nm. For negative controls, wells were
incubated with only the secondary antibody. The number of cells
per well was determined by DAPI (nuclear) staining.2.8. Statistics
Data are expressed as mean±SD. Statistical signiﬁcance among
groupswas analyzed byANOVA followed by the Fisher's least signiﬁcant
difference test. Pb0.05 was considered statistically signiﬁcant.3. Results
3.1. FGF2 induces crystallin expression in mLEC
Many previous studies have used capsule epithelial explants of the
lens to investigate the role of FGF2 in ﬁber cell differentiation [28–30];
however, we used mLEC instead. We ﬁrst needed to establish that
capsule-free mLEC would synthesize crystallins in response to FGF2
treatment. For this experiment, Wt mLEC were incubated with
10–100 ng/ml of FGF2. Crystallin expression was assessed by ELISA
(Fig. 1). While control experiments (no FGF2) showed very little
crystallin expression, the addition of FGF2 dramatically increased
expression of all crystallins (αA-, αB-, β-, and γ-crystallins). As cells
exposed to 100 ng/ml of FGF2 exhibited high levels of crystallin
expression, we decided to use this concentration in all subsequent
experiments.Fig. 1. FGF2 induces expression of crystallins in mLEC.WtmLEC were treated with FGF2
(0–100 ng/ml) for 5 days. ELISAwas performedwith cell lysate proteins forαA-,αB-,β-,
andγ-crystallin expression. Results are expressed asmean±SD from three independent
experiments.3.2. KYN blocks FGF2-induced crystallin expression
To study the effect of exogenous KYN,WtmLECwere culturedwith
FGF2 in the presence or absence of KYN. Similar to Fig. 1, addition of
100 ng/ml of FGF2 drastically increased all crystallin expression
(Fig. 2A). However, in the presence of KYN, FGF2 failed to elicit a
response; the crystallin levels were similar to those in untreated cells.
Thus, KYN appears to have blocked FGF2-induced expression of all
major crystallins. Furthermore, we performed immunoblot and
scanning densitometric analyses of crystallins and found that FGF2
increases expression of all crystallins (Fig. 2B). However, in cells
treated with FGF2+KYN, crystallin expression was comparable to
that of control. It is possible that the antibodies for crystallins did not
react with KYN-modiﬁed crystallins, and this contributed to the
decreased protein levels in KYN treated cells. To verify this possibility,
we performedWestern blots for all crystallins with Wt mLEC proteins
reacted with KYN (0.5 nmol/100 μg protein) for 48 h. This is based on
our previous observation that KYN concentration in KYN-treated Wt
mLEC is ∼0.12 nmol/50 µg protein/106 cells [13]. Obviously, the KYN
concentration used in the present study is higher than in our previous
study. Even with this higher KYN concentration, when higher KYN-
modiﬁcation on protein is expected, the antibody reactions were
similar between KYN-reacted and unreacted samples (Fig. 2C). These
results suggest that exogenous KYN blocked FGF2-induced expression
of crystallins, and the reduced crystallin levels are not due to the
failure of the antibodies to react with KYN-modiﬁed crystallins.
The above data suggests that exogenous KYN entered cells and
blocked expression of crystallins. To further verifywhether KYN formed
in cells could block crystallin expression, we used IDO overexpressing
hemTg mLEC. In some cases, we treated these cells with 20 μM MT to
block IDO activity. This concentration of MT was used based on our
previous study that showed a complete inhibition of IDO in IDO hemTg
mLEC with 20 μM MT [13]. FGF2 failed to evoke crystallin induction in
IDO-overexpressing cells. The crystallin levelswere comparable to those
in control cells (no FGF2; Fig. 3A). However, cotreatment of cells with
FGF2 and MT caused signiﬁcantly higher expression of all crystallins.
Western blot experiments and densitometric analyses corroborated the
ELISA results. The protein bands corresponding to crystallins were
denser in FGF2+MT-treated cells than in either controls or FGF2 alone-
treated cells (Fig. 3B). Taken together, these results strongly suggest that
endogenous KYN (produced by IDO activity) can block FGF2-induced
expression of all crystallins.
3.3. KYN does not affect FGF2 binding to cell surface receptors
The binding of the FGF2 to its cell surface receptor, which exhibits
receptor tyrosine kinase (RTK) activity, is the ﬁrst process in its signal
transduction. To determine if KYN affects FGF2 binding to its receptors,
and thereby blocks FGF2-mediated signaling required for crystallin
expression, we performed immunostaining for FGF2. In Wt mLEC
treated with FGF2, we observed immunoreactivity throughout cells
(Fig. 4A). This was unaltered in cells simultaneously incubated with
FGF2 andKYN. In hemTgmLEC (Fig. 4B), similar immunoreactivitywas
detected in cells exposed to FGF2with orwithoutMT. To further verify
the effect of KYN on FGF2 binding, we performed ELISA using whole
cells. FGF2 levels were nearly 4-fold higher in FGF2-treated cells than
in control cells (Fig. 4C), and KYN or MT had no effect on FGF2 levels
(Figs. 4C andD). Cells incubatedwith the secondary antibody alone did
not show immunoreactivity either (data not shown). These results
conﬁrmed that neither the exogenous nor the endogenous KYN alters
FGF2 binding to cells.
3.4. MIP26 expression is inhibited by KYN
FGF2 is known to induce MIP26 expression [26,31]. A recent study
showed that 100 ng/ml FGF2 induced MIP26 expression in rat lens
Fig. 2. Exogenous KYN inhibits crystallin expression in mLEC. (A) ELISA was performed using 1 µg proteins fromWt mLEC that were treated with FGF2 (100 ng/ml) and kynurenine
(KYN, 50 µM). Results are expressed as mean±SD from three independent experiments. (B) Cell lysate proteins (75 µg) were subjected to Western blotting. The blot was initially
probed for crystallins and subsequently striped and reprobed for GAPDH (loading control). The band intensities were quantiﬁed by scanning densitometry and expressed relative to
GAPDH (bottom panels). (C) Cell lysate protein (100 μg) reacted with or without KYN (0.5 nmol) was subjected to Western blotting. The blot was initially probed for crystallins and
subsequently striped and reprobed for GAPDH (loading control). Data are mean±SD from three independent experiments. *Pb0.001 in comparison to controls.
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used in our experiments. We tested the effect of KYN on MIP26
expression in mLEC by Western blotting and immunocytochemistry.
As can be seen in Fig. 5A, MIP26 was detected in all cells. In the case of
Wt mLEC, a prominent band corresponding to MIP26 protein was
detected in FGF2-treated cells. KYN dramatically reduced the effect of
FGF2 on MIP26 expression. Densitometric analysis showed a 7-fold
increase in MIP26 content in FGF2-treated cells and a content equal to
control cells in FGF2+KYN-treated cells. In the case of hemTg mLEC,
FGF2 mildly induced the expression of MIP26, and when added with
MT, the expression was signiﬁcantly increased (Fig. 5B).
Immunocytochemistry was performed to conﬁrm the above
ﬁndings. We found a higher expression of MIP26 in FGF2 treated WtmLEC (Fig. 5C). The immunoreactivity was relatively low in the
presence of FGF2+KYN. The MIP26 immunoreactivity was elevated
in FGF2-treated hemTg mLEC (Fig. 5D), and it was further elevated
when MT was included along with FGF2 (Fig. 5D). These results show
that FGF2-induced MIP26 expression is blocked by KYN, and
inhibition of IDO by MT reverses the effect of KYN and suggests that
KYN is inhibitory for FGF2-induced MIP26 expression in mLEC.
3.5. Akt activation is blocked by KYN
The P13K/Akt pathway has been implicated in the FGF2-induced
expression of lens crystallins [25]. To better understand the mechan-
isms behind the effect of KYN on crystallin expression, we examined
Fig. 3. Endogenous KYN inhibits crystallin expression in mLEC. (A) ELISAwas performed using 1 µg proteins from IDO hemTgmLEC that were treated with FGF2 (100 ng/ml) andMT
(20 µM). Results are expressed as mean±SD from three independent experiments. (B) Western blotting was performed as described in Fig. 2. Data are mean±SD from three
independent experiments. *Pb0.001 in comparison to controls.
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presence or absence of KYN. Western blot results showed higher
levels of pAkt in cells treated with FGF2 (∼8-fold higher over control),
but this effect was absent in cells treatedwith FGF2+KYN (Fig. 6A). In
the case of hemTg mLEC, FGF2 failed to induce a response similar to
Wt mLEC; pAkt levels were relatively low (Fig. 6B). However, when
cells were incubated with FGF2+MT, pAkt levels were drastically
increased. The total Akt level in both cases remained similar to the
levels in untreated cells.
Consistent with Western blot ﬁndings, immunoreactivity to pAkt
was much higher in FGF2 treated Wt mLEC (Fig. 6C) and FGF2+
MT-treated hemTg mLEC (Fig. 6D). Together, these data imply that
KYN blocks FGF2-induced Akt activation.
3.6. FGF2-induced ERK1/2 phosphorylation is inhibited in the presence
of KYN
ERK1/2 activation has been identiﬁed as essential for FGF2-
induced MIP26 expression [26]. To determine if the low MIP26
expression in the presence of KYN is due to KYN's effect on ERK1/2
phosphorylation, we investigated phosphorylation proﬁle of ERK1/2
in FGF2-treated mLEC. Figs. 7A and B show total and phosphorylatedERKs inWt and IDO hemTg mLEC, respectively. The two isoforms, p44
(ERK1) and p42 (ERK2), are both phosphorylated by FGF2 in Wt cells,
and KYN inhibited such phosphorylation. In IDO hemTg mLEC,
phosphorylation of both is induced by FGF2; however, the induction
was more robust in MT-treated cells.
We then performed immunocytochemistry to conﬁrm Western
blot results. Immunoreactivity to total ERK1/2 was detected both in
Wt and hem Tg mLEC treated with or without FGF2 (Figs. 7C and D).
However, immunoreactivity to pERK1/2 was greater in FGF2-treated
Wt mLEC (Fig. 7E) and in FGF2+MT-treated hemTg mLEC (Fig. 7F)
compared to untreated Wt mLEC and FGF2-treated IDO hemTg mLEC,
respectively. These data indicate that the inhibitory effect of KYN on
MIP26 is due to the inhibition of upstream ERK1/2 phosphorylation.
3.7. KYN inhibits FGF2-mediated NF-κB activation
To further conﬁrm that KYN adversely affects FGF2 signaling, we
studied its effect on NF-κB activation,which is known to be activated by
FGF2 in lens epithelial cells [32]. Results showed that KYN inhibited
FGF2-mediated NF-κB (p65) nuclear translocation (activation) in Wt
mLEC (Fig. 8A). In the case of hemTg mLEC, NF-κB (p65) nuclear
translocation was greater in cells treated with FGF2+MT than in cells
Fig. 4. KYN does not inhibit FGF2 binding to cell surface receptors. Wt (A and C) and IDO hemTg mLEC (B and D) cultured in the presence of FGF2 (100 ng/ml) and with or without
kynurenine (KYN, 50 µM) and MT (20 µM). (A and B) Immunocytochemistry for FGF2. The immunoreactivity for FGF2 was detected using Oregon Green goat anti-rabbit secondary
antibody. Cells were counterstained with a nuclear stain, DAPI (blue). Figures are representative of three independent experiments. (C and D) FGF2 binding was analyzed by an ELISA
using a rabbit anti-FGF2 polyclonal antibody and goat anti-rabbit IgG HRP conjugate. The number of cells per well was determined by DAPI staining. The y-axis represents OD/cell
and was calculated by dividing total OD by the cell number. Data are expressed as mean±SD from three independent experiments. Neither exogenous nor endogenous KYN affect
FGF2 binding to cell surface. *Pb0.05 in comparison to controls.
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nuclear fraction of control samples (no KYN). Consistent with the
Western blot ﬁndings, immunoreactivity for NF-κB (p65) in the nucleus
was greater in FGF2-treatedWt mLEC (Fig. 8C) than controls (no KYN).
FGF2+MT-treated hemTgmLEC showedhigher immunoreaction in the
nucleus than cells without treatment (Fig. 8D). Together, these data
imply that KYN blocks FGF2-induced NF-κB activation.
3.8. KYN blocks phosphorylation of FGFR1
Following FGF ligand binding and dimerization, FGFRs get phos-
phorylated at tyrosine residues [33]. FGFR1 can be phosphorylated at
seven tyrosine residues in the cytoplasmic tail. Of these, tyrosine 653
and 654 are important for signaling [34]. To test if KYN interferes with
FGFR1 phosphorylation, we performed Western blotting for pFGFR1
(Tyr653/654). A prominent band corresponding to pFGFR1 was
detected in FGF2-treated Wt mLEC (Fig. 9). KYN blocked phosphory-
lation of FGFR1. In the case of hemTgmLEC, amore prominent bandwasdetected in FGF2+MT-treated cells than in FGF2 alone-treated cells.
Together, these results suggest that KYN blocks its phosphorylation.
4. Discussion
The role of FGF2 in normal lens development and transparency is
well established [35,36]. Molecular and genetic approaches have
recently identiﬁed a series of signaling molecules that participate in
these processes. However, whether low-molecular weight compounds
present in the lens affect these pathways remains unknown. In the
present study, for the ﬁrst time, we provide evidence for KYN-mediated
blockade of FGF2 signaling pathway.
In the human lens, kynurenines absorb UV light penetrating the
cornea (300–400 nm) [5,37–39]. By absorbing UV light, they could
protect the retina fromphotodamage. However, recent reports suggest a
potential role for KYN in cataract formation. Our recent studies with
transgenicmiceprovide evidence for thedeleterious effects of KYN in the
lens [12,13]. In those studies, we found that IDO overexpression in the
Fig. 5. KYN inhibits FGF2-induced expression of MIP26. Wt mLEC and IDO hemTg mLEC were treated with or without FGF2 (100 ng/ml). In addition to FGF2, Wt mLEC were treated
with kynurenine (KYN, 50 µM), and IDO hemTg mLEC were treated with MT (20 µM) for 5 days. Cell lysates (75 µg protein in each case) fromWt (A) and IDO hemTg mLEC (B) were
subjected toWestern blotting using an anti-MIP26 antibody. The membrane was reprobed for GAPDH (loading control). Images are representative of two independent experiments.
Band intensities of MIP26 relative to GAPDH are average of two independent experiments (middle panels). Immunocytochemistry for MIP26 was performed with rabbit anti-FGF2
polyclonal antibody and Oregon Green goat anti rabbit IgG in Wt mLEC (C) and IDO hemTg mLEC (D). Cells were counterstained with a nuclear stain, DAPI (blue). MIP26 expression
was inhibited by KYN in Wt mLEC and restored by MT treatment in IDO hemTg mLEC.
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epithelial cells [12,13]. Furthermore,we foundhigh levels ofKYN in those
epithelial cells. Based on the results, we concluded that KYN, produced
through IDO, was causing protein modiﬁcation and cell cycle arrest.
The present study extended these ﬁndings in order to further
investigate the effect of KYN on LEC. The major ﬁndings in the present
study are as follows: (1) FGF2 induces expression of allmajor crystallins
and MIP26 in mLEC. (2) KYN blocks FGF2-induced expression ofcrystallins and MIP26. (3) KYN reduces FGF2 induced phosphorylation
of FGFR1, Akt, and ERK1/2. (4) Inhibition of IDO reverses KYN-mediated
blockade of FGF2 signaling.
We used 50 μM KYN to study effects of exogenous KYN. In our
previous study, we measured KYN concentration in mLEC incubated
with 50 μMKYNand found that the levelswithin cells are∼0.12 nmol/
106 cells and are comparable to those in IDO hemizygous lens
epithelial cells (∼0.11 nmol/106 cells) [12]. Thus, the KYN
Fig. 6. KYN inhibits FGF2-induced Akt phosphorylation. Cells were treated as described in Fig. 5. Cell lysates (75 µg protein each) from Wt (A) and IDO hemTg mLEC (B) were
subjected to Western blotting. The blot was initially probed for pAkt and subsequently reprobed for total Akt. Images are representative of two independent experiments. Band
intensities of pAkt relative to Akt are average of two independent experiments (middle panels). Wt (C) and IDO hemTg mLEC (D) were ﬁxed, permeabilized, and subjected to
immunocytochemistry using a rabbit anti pAkt polyclonal antibody and Oregon Green goat anti-rabbit IgG. Cells were counterstained with a nuclear stain, DAPI (blue). FGF2-induced
Akt phosphorylation is inhibited by KYN in Wt mLEC and restored by MT treatment in IDO hemTg mLEC. Images are representative of two independent experiments.
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present in LEC of IDO transgenic animals. Because neither KYN
incubated mLEC nor lens epithelial cells of IDO transgenic animals
showed NFK or 3OH-KYN, but they did show high levels of KYN [12],
we believe that the effects seen the present study are primarily due to
KYN. Moreover, at the concentration used in the present study
(50 μM), we did not detect cell death in mLEC during the 5-day
incubation period. This is consistent with our previous ﬁnding [13].
Furthermore, our previous study had shown that KYN concentrations
within mLEC remained unchanged when we increased the KYN
concentration from 50 to 200 μM, suggesting that mLEC have theability to regulate intracellular concentrations of KYN. The highest
intracellular concentration of KYN achieved in that study was
0.12 nmol/106 cells with 50 μM KYN. The absence of cell death at
this concentration of KYN suggests thatmLECmay either have a robust
mechanism to cope with KYN or that KYN does not cause apoptosis at
this concentration.
Bindingof FGF2 toRTKsactivates the intrinsic tyrosinekinase resulting
in tyrosinephosphorylation, further activating thePI3K/Akt andmitogen-
activated protein kinase (MAPK) pathways [40]. It has been reported that
in differentiating LEC, ERK1/2-JNK activation is necessary for MIP26
expression [26], and Akt activation is necessary for β- and γ- crystallin
Fig. 7. KYN inhibits FGF2-induced ERK1/2 activation. Cells were treated as described in Fig. 5. Cell lysate corresponding to 75 µg protein fromWt (A) and IDO hemTg mLEC (B) was
subjected to Western blotting. The blot was initially probed for total ERK1/2 and later for pERK1/2. Images are representative of two independent experiments. Band intensities of
pERK1 and pERK2 relative to ERK1 and ERK2, respectively, are average of two independent experiments (middle panels). mLEC from Wt (C and E) and IDO hemTg (D and F) were
ﬁxed, permeabilized, and subjected to immunocytochemistry with an anti- ERK1/2 polyclonal antibody (C and D) or an anti-pERK1/2 polyclonal antibody (E and F). Oregon Green
goat anti-rabbit IgG was used as the secondary antibody. Cells were counterstained with a nuclear stain, DAPI (blue). Images are representative of two independent experiments.
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epithelial cells express α-crystallins and FGF2 induces its expres-
sion [41,42]. Nevertheless, our ﬁnding that KYN blocks FGF2-induced
ERK1/2 and Akt phosphorylation provides a mechanistic explanation for
the reduced crystallinandMIP26expressionbyKYN.Wealso showed thatKYN blocks FGF2-induced NF-κB activation, which provides additional
support to our hypothesis that KYN blocks FGF2 signaling in mLEC.
Because our results suggested that FGF2 signaling is impaired by
KYN, we determined whether FGF2 binding to mLEC was altered by
KYN. Although we found no evidence for alteration in FGF2 binding to
Fig. 8. KYN inhibits FGF2-mediated NF-κB nuclear translocation. Cells were treated as described in Fig. 5. Nuclear protein fractions (75 µg protein each case) from Wt (A) and IDO
hemTg mLEC (B) were subjected to Western blotting and probed for NF-κB (p65). Images are representative of two independent experiments. After treatment, mLEC from Wt
(C) and IDO hemTg (D) were permeabilized and subjected to immunocytochemistry with an anti- NF-κB (p65) polyclonal antibody. Texas Red donkey anti-goat IgG was used as the
secondary antibody. Cells were counterstained with a nuclear stain, DAPI (blue). Images are representative of two independent experiments.
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studies are required to understand the mechanisms by which KYN
reduces FGFR1 phosphorylation.
FGF2-mediated signaling occurs through its high-afﬁnity cell
surface receptors that contain four major domains that are rich inFig. 9. KYN inhibits phosphorylation of FGFR1. Cellswere treated as described in Fig. 5. Cell
lysate corresponding to 75 µg of protein fromWt and IDO hemTg mLEC was subjected to
Western blotting. The blot was initially probed for pFGFR1 and subsequently for GAPDH.
Images are representative of two independent experiments. Band intensities of pFGFR1
relative to GAPDH are average of two independent experiments (bottom panel).cysteine [43]: the extracellular domain responsible for ligand
binding, the tyrosine kinase domain that transmits biological signal
intracellularly, the transmembrane domain that connects the
extracellular and intracellular domains, and the regulatory domain
with many autophosphorylation sites. It is possible that KYN reacts
with cysteines in these domains and alters their function. This
notion is supported by several observations. KYN is intrinsically
unstable and undergoes deamination to form a reactive α,β-
unsaturated ketone [8,44], which rapidly reacts with nucleophilic
amino acids, such as cysteine in proteins. It was found that the rate
constant for the addition of KYN derived oxo acid to cysteine is 36
±4/L/mol/s, which is several orders of magnitude higher than the
rate with other amino acids. The rate constant for the addition
reaction to L-GSH is only 2.1±0.24/L/mol/s [45]. This implies that
cysteine residues in proteins are most susceptible for modiﬁcation
by KYN even in presence of GSH.
In addition to their receptors, FGFs bind to heparan sulfate in
proteoglycan of cell membrane and extracellular matrix through a
heparin sulfate binding domain [46,47]. It has been proposed that
heparin sulfate facilitates binding of FGF2 to FGFR. The anterior
capsule of the lens contains heparin sulfate [48]. Considering that we
used isolated LEC in the present study rather than lens epithelial
explants that contain the lens capsule, we do not believe that the
defective FGF2 signaling occurred due to an effect of KYN on heparin
sulfate. Nevertheless, additional work is required to rule out such an
effect in lens in vivo.
In cultured human lens epithelial cells (HLE-B3 cells), we have
measured IDO activity and found it be∼0.1 nmol of KYN/h/mg protein,
andwe found that this activity to increase by 200-foldwith pathological
concentrations of interferon-γ (Mailankot and Nagaraj, unpublished
observation). Interferon-γ (IFN-γ) is themost abundant cytokine in the
aqueous humor in infectious and noninfectious uveitis [49]. IFN-γ is a
known stimulator of IDO synthesis [1]. Since IDO is presentmostly in the
epithelium of the lens [50], we can speculate that, in inﬂammatory
conditions of the eye, KYN concentrations in the lens could be
profoundly higher than normal concentrations of 2–40 μM [51]. Under
Fig. 10. Conceptual view on the mechanism of KYN-mediated inhibition of protein synthesis in mLEC. Both exogenous and endogenous KYN inhibit FGF2-induced FGFR1
phosphorylation, which results in decreased activation of Akt and ERK1/2 and, consequently, reduced expression of crystallins and MIP26.
619M. Mailankot et al. / Biochimica et Biophysica Acta 1802 (2010) 609–620such circumstances, elevated KYN could impair FGF2 signaling in LEC
and consequently affect lens transparency (Fig. 10).
We believe that our ﬁndings are relevant not only for lens epithelial
cell biology but also for neurological diseases. For example, in
Alzheimer's disease, levels of kynurenine are elevated in the brain.
The activation of IDO inmicroglial cells of the brain is believed to be the
cause of higher production of kynurenines [52,53]. Furthermore, FGF2
is increased in the brains of Alzheimer's patients [54]. Thus, FGF2-
mediated signalingmay be impaired and could contribute to pathology
in Alzheimer's disease. Furthermore, high levels of kynurenines have
been detected in Huntington's disease as well [55]. It will be important
to determine if FGF2-mediated signaling pathways are similarly
affected in this disease. In summary, our study shows for the ﬁrst
time that an intracellular metabolite of the kynurenine pathway could
speciﬁcally downregulate a signaling pathway that is important for the
synthesis of major proteins of an organ.
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